Boule Diagnostics AB (publ) has carried out a preferential rights issue of shares of approximately SEK 150 million.

Boule Diagnostics is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally through distributors, supported by Boule’s own local sales and support personnel.

Pareto Securities acted as Sole Manager and Bookrunner. Baker McKenzie acted as legal advisor to Pareto Securities with a capital markets team consisting of Joakim Falkner and Johanna Flink.

Explore Our Newsroom